Biomaterials Market by Type (Metallic, Ceramic, Polymers, and Natural); Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Neurological Disorders, Tissue Engineering, and Ophthalmology): Global Market Size Estimates and Forecast (2022-2030)

Code: BMIRE00026441 | Pages: 100 | Industry: Medical Device | Date: Sep 2022 | Type: Global

The market crossed the US$ 144.2 billion mark in 2022 and is expected to hit US$ 401.4 billion by 2030, recording a CAGR of 13.3% during the forecast period


The biomaterials market has been significantly growing with the high adoption of new technologies

Biomaterial technologies contribute to developing new efficient personal protective equipment, drug deliveries, vaccines, and new therapeutics used to prevent or treat the infection from SARS-COV-2. Furthermore, cell-cultured models and engineered tissues significantly impacted investigating the condition, testing, and developing vaccines and therapeutics. The advanced technology has made biomaterials more versatile and has increased their utility in various healthcare fields, such as tissue and bioengineering.

Within the report, the market is segmented into type and application. Based on type, the market is segmented into metallic, ceramic, polymers, and natural. Based on application, the market is segmented into cardiovascular, orthopedic, dental, plastic surgery, wound healing, neurological disorders, tissue engineering, and ophthalmology. Geographically, the market is sub-segmented into North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa.

Get more information on this report :

The polymer product segment will empower the growth of the market

The polymer product segment will continue leading with a wide range of product applications throughout the forecast period. The availability of biopolymers and advanced polymers for bio-resorbable tissue fixation and other orthopedic applications is expected to accelerate growth. Polymeric biomaterials are one of the cornerstones of tissue engineering. Ongoing progression, such as micro-manufacturing, surface modification, drug delivery, nanotechnology, and high-throughput screening, play an integral role in broadening polymeric material usage in tissue engineering. Natural biomaterials own various benefits over synthetic biomaterials in biodegradability, biocompatibility, and remodeling.

Increased funds and grants by government bodies are one of the major factors accelerating the market growth

The demand for biomaterials in various medical applications has increased globally. Many government bodies have extended their help in the form of investments, funds, and grants to promote research on developing novel biomaterials. For instance, On 13 September 22, ViVita Technologies, Inc., a life science startup developing bioactive biomaterials for tissue and organ regeneration, was awarded a $1.5 million SBIR (Small Business Innovation Research) Phase II grant by the NHLBI (National Heart, Lung, and Blood Institute) of NIH (National Institutes of Health). This funding enables the final characterization and evaluation of the BARE (Biocompatible and Regenerative Extracellular Matrix) Patch product towards FDA 510(k) clearance for clinical cardiovascular indications and the foundational dataset of an Investigational Device Exemption (IDE) application for heart valve indications.

Recent strategic developments in the biomaterials market

The biomaterials market has undergone several significant developments, and a few of these have been mentioned below:

  • In Sep 2020, DSM announced a collaboration with PBC Biomed to jointly design and develop novel materials for medical devices. The focus is on the development of bone adhesives through PBC Biomed's affiliate, Biomimetic Innovations, which could help to meet the need for safer, less invasive surgical procedures that are also more cost-effective
  • In Jan 2021, Dentsply Sirona announced the acquisition of Datum Dental, Ltd. with its strong OSSIX biomaterial portfolio

The biomaterials market is driven by several players by implementing strategic activities such as investments, new launches, mergers & acquisitions, and partnerships. Covestro AG; Dentsply Sirona; Corbion N.V.; Koninklijke DSM N.V.; Evonik Industries; CRS Holdings, LLC.; Berkeley Advanced Biomaterials; CoorsTek, Inc.; CeramTec; and GELITA AG are among the prominent players operating in the market.

The target audience for the report:

  • Raw material providers
  • Related associations, organizations, forums, and alliances
  • Government bodies, such as regulating authorities and policymakers
  • Venture capitalists and start-up companies
  • End users
  • Research institutes, organizations, and consulting companies

Scope of the report:

In this report, the market has been segmented based on:

  • Type:
    • Metallic
    • Ceramic
    • Polymers
    • Natural


  • Application:
    • Cardiovascular
    • Orthopedic
    • Dental
    • Plastic Surgery
    • Wound Healing
    • Neurological disorders
    • Tissue Engineering
    • Ophthalmology
  • Region
    • North America
    • Europe
    • Asia Pacific
    • South & Central America
    • Middle East & Africa
  • Companies profiled
  • Covestro AG
  • Dentsply Sirona
  • Corbion N.V.
  • Koninklijke DSM N.V.
  • Evonik Industries
  • CRS Holdings, LLC.
  • Berkeley Advanced Biomaterials
  • CoorsTek, Inc.
  • CeramTec

Companies profiled
- Covestro AG
- Dentsply Sirona
- Corbion N.V.
- Koninklijke DSM N.V.
- Evonik Industries
- CRS Holdings, LLC.
- Berkeley Advanced Biomaterials
- CoorsTek, Inc.
- CeramTec

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Purchase Options
Single User License
Site License
Enterprise License